Cortical demyelination in multiple sclerosis: A substrate for cognitive deficits?

Journal of the Neurological Sciences

Volumn 245, Issue 1-2, 2006, Pages 123-126

  Kutzelnigg, Alexandra ^a   Lassmann, Hans ^a  

^a Medical University of Vienna   (Austria)

Author keywords

Cognitive deficit; Cortex; Demyelination; Multiple sclerosis

Indexed keywords

ARTICLE; BRAIN CORTEX; COGNITIVE DEFECT; DEMYELINATION; DISEASE CLASSIFICATION; HUMAN; HUMAN TISSUE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL;

ADULT; AGED; CEREBRAL CORTEX; COGNITION DISORDERS; DEMYELINATING DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POSTMORTEM CHANGES;

EID: 33646829924     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2005.09.021     Document Type: Article

References (22)

1. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N Engl J Med 343 (2000) 938-952
2. Brownell B., and Hughes J.T. The distribution of plaques in the cerebrum in multiple scleosis. J Neurol Neurosurg Psychiatry 25 (1962) 315-320
3. Lumsden C.E. The neuropathology of multiple sclerosis. In: Vinken P.I., and Bruyn G.W. (Eds). Handbook of Clinical Neurology vol. 9 (1970), Elsevier, New York 217-309
4. Kidd T., Barkhof F., McConnell R., Algra P.R., Allen I.V., and Revesz T. Cortical lesions in multiple sclerosis. Brain 122 (1999) 17-26
5. Bo L., Vedeler C.A., Nyland H.I., Trapp B.D., and Mork S.J. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 62 (2003) 723-732
6. Peterson J.W., Bo L., Mork S., Chang A., and Trapp B.D. Transsected neurites, apoptotic neurons and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 50 (2001) 389-400
7. Bo L., Vedeler C.A., Nyland H., Trapp B.D., and Mork S.J. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 9 (2003) 323-331
8. Bien C.G., Bauer J., Deckwerth T.L., Wiendl H., Deckert M., Wiestler O.D., et al. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen's encephalitis. Ann Neurol 51 (2002) 311-318
9. Lucchinetti C., Brück W., Parisi J., Scheithauer B., Rodriguez M., and Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47 (2000) 707-717
10. Brink B.P., Veerhuis R., Breij E.C., van der Valk P., Dijkstra C.D., and Bo L. The pathology of multiple sclerosis is location dependent: no significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 64 (2005) 147-155
11. Pagani E., Rocca M.A., Gallo A., Rovaris M., Martinelli V., Comi G., et al. Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. Am J Neuroradiol 26 (2005) 341-346
12. Chen J.T., Narayanan S., Collins D.L., Smith S.M., Matthews P.M., and Arnold D.L. Relating neocortical pathology to disability progression in multiple sclerosis using MRI. Neuroimage 23 (2004) 1168-1175
13. Sarchielli P., Presciutti O., Tarducci R., Gobbi G., Alberti A., Pelliccioli G.P., et al. Localized (1) H magnetic resonance spectroscopy in mainly cortical gray matter of patients with multiple sclerosis. J Neurol 249 (2002) 902-910
14. De Stefano N., Matthews P.M., Filippi M., Agosta F., De Luca M., Bartolozzi M.L., et al. Evidence for early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 60 (2003) 1157-1162
15. Richert N.D., Ostuni J.L., Bash C.N., Duyn J.H., McFarland H.F., and Frank J.A. Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b. Am J Neuroradiol 19 (1998) 1705-1713
16. Piras M.R., Magnano I., Canu E.D., Paulus K.S., Satta W.M., Soddu A., et al. Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological and neurophysiological findings. J Neurol Neurosurg Psychiatry 74 (2003) 875-885
17. Christodoulou C., Krupp L.B., Liang Z., Huang W., Melville P., Roque C., et al. Cognitive performance and MRI markers of cerebral injury in cognitively impaired MS patients. Neurology 60 (2003) 1793-1798
18. Geurts J.J., Bo L., Pouwels P.J., Castelijns J.A., Polman C.H., and Barkhof F. Cortical lesions in multiple sclerosis: combined postmortem MR imaging and histopathology. Am J Neuroradiol 26 (2005) 572-577
19. Rovaris M., Filippi M., Minicucci L., Ianucci G., Santuccio G., Possa F., et al. Cortical/subcortical disease burden and cognitive impairment in patients with multiple sclerosis. Am J Neuroradiol 21 (2000) 402-408
20. Charil A., Zijdenbos A.P., Taylor J., Boelman C., Worsley K.J., Evans A.C., et al. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 19 (2003) 532-544
21. Au Duong M.V., Boulanouar K., Audoin B., Treseras S., Ibarrola D., Malikova I., et al. Modulation of effective connectivity inside the working memory network in patients at the earliest stage of multiple sclerosis. Neuroimage 15 (2005) 533-538
22. Ranjeva J.P., Audoin B., Duong M.V., Ibarrola D., Confort Gouny S., Malikova I., et al. Local tissue damage assessed with statistical mapping analysis of brain magnetization transfer ratio: relationship with functional status of patients in the earliest stage of multiple sclerosis. Am J Neuroradiol 26 (2005) 119-127